Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Integra Lifesciences
(NQ:
IART
)
28.34
-0.07 (-0.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
446,577
Open
28.42
Bid (Size)
24.55 (2)
Ask (Size)
28.34 (13)
Prev. Close
28.41
Today's Range
28.13 - 28.81
52wk Range
27.18 - 56.21
Shares Outstanding
84,579,542
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
March 27, 2024
From
Pomerantz LLP
Via
GlobeNewswire
NASDAQ:IART is probably undervalued for the fundamentals it is displaying.
March 25, 2024
INTEGRA LIFESCIENCES HOLDING (NASDAQ:IART) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Performance
YTD
-34.47%
-34.47%
1 Month
-18.63%
-18.63%
3 Month
-32.27%
-32.27%
6 Month
-17.16%
-17.16%
1 Year
-48.68%
-48.68%
More News
Read More
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
March 07, 2024
Via
Benzinga
NASDAQ:IART, an undervalued stock with good fundamentals.
March 04, 2024
Via
Chartmill
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
February 29, 2024
Via
Benzinga
Recap: Integra Lifesciences Q4 Earnings
February 28, 2024
Via
Benzinga
The Analyst Landscape: 7 Takes On Integra Lifesciences
December 22, 2023
Via
Benzinga
The Latest Analyst Ratings for Integra Lifesciences
December 05, 2023
Via
Benzinga
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 14, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Neurosurgery Focused Integra LifeSciences Bolsters Its ENT Portfolio With $275M Acquisition Deal
December 13, 2023
Via
Benzinga
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday
December 05, 2023
Via
Benzinga
4 Analysts Have This to Say About Integra Lifesciences
November 14, 2023
Via
Benzinga
INTEGRA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
November 10, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INTEGRA LIFESCIENCES 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Integra LifeSciences Holdings Corporation - IART
November 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Integra LifeSciences Holdings Corporation (IART)
November 10, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INTEGRA INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
November 09, 2023
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
ROSEN, A LEADING NATIONAL FIRM, Encourages Integra LifeSciences Holdings Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important November 13 Deadline in Securities Class Action - IART
November 09, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
November 08, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
IART DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - IART
November 07, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ: IART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Integra LifeSciences Holdings Corporation
November 07, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Investor Notice: Deadline on November 13, 2023 Coming Up in Lawsuit Against Integra LifeSciences Holdings Corporation (NASDAQ:IART)
November 06, 2023
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING INVESTOR COUNSEL, Encourages Integra LifeSciences Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IART
November 05, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
INTEGRA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Integra To Contact Him Directly To Discuss Their Options
November 04, 2023
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
INTEGRA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Integra LifeSciences Holdings Corp. and Encourages Investors to Contact the Firm
November 03, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Integra LifeSciences Holdings Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IART
November 03, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.